Clinical Trials Directory

Trials / Conditions / Locally Advanced Gastroesophageal Junction Adenocarcinoma

Locally Advanced Gastroesophageal Junction Adenocarcinoma

7 registered clinical trials studyying Locally Advanced Gastroesophageal Junction Adenocarcinoma — 5 currently recruiting.

StatusTrialSponsorPhase
RecruitingTesting the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in P
NCT06364410
National Cancer Institute (NCI)Phase 1
RecruitingPropranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Loca
NCT05651594
Roswell Park Cancer InstitutePhase 2
RecruitingPersonalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Soli
NCT05269381
Mayo ClinicPhase 1 / Phase 2
RecruitingS-1 and Oxaliplatin (SOX) Plus Sintilimab in the Locally Advanced Esophagogastric Junction Adenocarcinoma
NCT04989985
Sixth Affiliated Hospital, Sun Yat-sen UniversityPhase 2
RecruitingTrifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Color
NCT04511039
Roswell Park Cancer InstitutePhase 1
Active Not RecruitingPembrolizumab and Chemoradiotherapy for the Treatment of Unresectable Gastroesophageal Cancer
NCT04522336
M.D. Anderson Cancer CenterPhase 1
Active Not RecruitingSonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors
NCT04007744
Mayo ClinicPhase 1